We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITO
6351
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$27K ﹤0.01%
15,000
+14,600
+3,650% +$26.6K
MBII
6352
DELISTED
Marrone Bio Innovations, Inc.
MBII
$27K ﹤0.01%
23,308
-6,846
-23% -$6.33K
MFNC
6353
DELISTED
Mackinac Financial Corporation
MFNC
$27K ﹤0.01%
2,639
-2,744
-51% -$27.2K
LOAC
6354
DELISTED
Longevity Acquisition Corporation Ordinary Shares
LOAC
$27K ﹤0.01%
2,514
+2,214
+738% +$23.4K
LFACU
6355
DELISTED
LF Capital Acquistion Corp. Unit
LFACU
$27K ﹤0.01%
2,332
+100
+4% +$1.18K
MXDE
6356
DELISTED
Nationwide Maximum Diversification Emerging Markets Core Equity ETF
MXDE
$27K ﹤0.01%
1,285
+1,195
+1,328% +$23.3K
CEMI
6357
DELISTED
Chembio diagnostics, Inc.
CEMI
$27K ﹤0.01%
8,103
-6,940
-46% -$65.9K
ATNM icon
6358
Actinium Pharmaceuticals
ATNM
$25M
$26K ﹤0.01%
2,437
-1,924
-44% -$14.6K
BSBK icon
6359
Bogota Financial
BSBK
$111M
$26K ﹤0.01%
+2,940
New +$24.7K
BSMS icon
6360
Invesco BulletShares 2028 Municipal Bond ETF
BSMS
$316M
$26K ﹤0.01%
1,009
+974
+2,783% +$24.2K
COCP icon
6361
Cocrystal Pharma
COCP
$14.6M
$26K ﹤0.01%
1,445
+512
+55% +$6.27K
CTOS icon
6362
Custom Truck One Source
CTOS
$2.37B
$26K ﹤0.01%
6,369
+3,358
+112% +$9.77K
EEX
6363
DELISTED
Emerald Holding
EEX
$26K ﹤0.01%
8,399
-6,694
-44% -$15.9K
ETON icon
6364
Eton Pharmaceutcials
ETON
$1.22B
$26K ﹤0.01%
4,783
-1,948
-29% -$9.67K
HGLB
6365
Highland Global Allocation Fund
HGLB
$177M
$26K ﹤0.01%
4,046
+3,402
+528% +$19.3K
KOPN icon
6366
Kopin
KOPN
$791M
$26K ﹤0.01%
19,162
-7,095
-27% -$5.94K
KPLTW
6367
DELISTED
Katapult Holdings Warrant
KPLTW
$26K ﹤0.01%
25,000
MMI icon
6368
Marcus & Millichap
MMI
$1.19B
$26K ﹤0.01%
909
-12,536
-93% -$353K
BINI
6369
DELISTED
Bollinger Innovations
BINI
0
AIOS
6370
AIOS Tech
AIOS
$39M
$26K ﹤0.01%
+8
New +$20.1K
PEX icon
6371
ProShares Global Listed Private Equity ETF
PEX
$11.6M
$26K ﹤0.01%
+1,022
New +$24.9K
QEMM icon
6372
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$60.2M
$26K ﹤0.01%
488
-1,395
-74% -$70.1K
UITB icon
6373
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.65B
$26K ﹤0.01%
488
-507
-51% -$26.7K
FSGS
6374
First Trust SMID Growth Strength ETF
FSGS
$32.1M
$26K ﹤0.01%
+1,462
New +$24.4K
HEWG
6375
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$26K ﹤0.01%
953
-3,330
-78% -$82.7K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.